Pembrolizumab is prescribed for:
- Melanoma
- Non-small cell lung cancer
- Head and neck cancer
- Hodgkin lymphoma
- Many other cancers
- Oncology immunotherapy
One of the most widely used cancer immunotherapies.
Generic Name: Pembrolizumab
Brand Names: Keytruda
Pembrolizumab is a PD-1 immune checkpoint inhibitor used for many cancer types.
Pembrolizumab is prescribed for:
One of the most widely used cancer immunotherapies.
Common side effects:
Serious side effects (immune-mediated):
Pembrolizumab is a PD-1 checkpoint inhibitor that helps the immune system fight cancer.
Approved for more cancer types than any other immunotherapy, including tumor-agnostic indications.
Can cause inflammation in any organ - requires monitoring and may need steroids to manage.
Learn more at MedlinePlus.
This medication is commonly used to treat or manage the following conditions:
Medical Disclaimer: This information is for educational purposes only and should not be considered medical advice. Always consult with your healthcare provider before starting, stopping, or changing any medication. Your doctor can provide personalized recommendations based on your specific health condition and medical history.
Loading questions...
Have questions about Pembrolizumab? Get expert answers from Dr. Zimmer.
Privacy: Your questions are posted anonymously for your health privacy. Your name and email are only used for admin purposes.
Questions are reviewed before posting. You'll see your question and Dr. Zimmer's answer below once approved.